Comparison of Ondansetron versus Clonidine efficacy for prevention of postoperative pain, nausea and vomiting after orthognathic surgeries : a triple blind randomized controlled trial

The aim of this randomized controlled triple blind trial was to compare the efficacy of clonidine with dexamethasone versus ondansetron with dexamethasone for postoperative pain, nausea and vomiting prevention in orthognathic surgery patients. In this clinical trial study, 30 consecutive patients with skeletal class III deformities were candidates for orthognathic surgery in Qaem hospital, Mashhad University of medical sciences, Mashhad, Iran from March to November 2017. These subjects were randomly assigned to two equal number groups, ondansetron or clonidine. Patients received either oral ondansetron 8mg or oral clonidine 150?g as premedication, 1 hour before the surgery (both dissolved in 20 cc of water). Also both groups received intravenous dexamethasone 8mg (1 hour preoperatively and every 4 hours intraoperatively). In this study, a total of 30 patients (14 males and 16 females) with a mean age of 23.9 ± 3.9 were investigated. The incidence of postoperative nausea in women was more than men (p=0.003), also the correlation between the incidence of PON and the surgery duration ? 3 hours was statistically significant (p = 0.050). The frequency of postoperative nausea (PON) in the ondansetron group was less than clonidine (53.3% vs 73.3% respectively). There was no postoperative vomiting (POV) in the ondansetron group, but 6.7% of cases in clonidine group suffered POV. Post-operative nausea in ondansetron group occurred significantly later than clonidine (525.0±233.2 vs 100.0±34.0 min; p<0.001). On the other hand, the incidence time of post-operative severe pain or in other word the analgesia time in clonidine group was significantly more than ondansetron one (875/0±68/5 vs 614.3±159.1 min; p<0.001). Ondansetron with dexamethasone premedication was more effective in controlling PONV after orthognathic surgery compared to clonidine with dexamethasone group

Endovascular treatment of an unruptured anterior communicating artery aneurysm presenting with acute altitudinal visual field defect: A case report

Purpose: To describe a case of endovascular occlusion of an unruptured anterior communicating artery aneurysm presenting with acute altitudinal visual field defect is presented here. Methods: A 52-year-old man was evaluated and treated for altitudinal visual field defect in the right eye. Results: In ophthalmic and neuro-imaging, an accompanying anterior communication artery aneurysm was detected as a cause of visual field defect. He underwent endovascular procedure, yielding excellent outcome as full recovery of visual field defect was observed one month following the procedure and sustained when followed at month 24. Conclusions: Visual dysfunction is a rare presentation of unruptured anterior communication artery aneurysm. Endovascular procedure may be a safe treatment in these cases. Keywords: Intracranial aneurysm, Anterior communicating artery, Visual field, Endovascular procedur

Combined Keratocystic Odontogenic Tumor and Basal Cell Ameloblastoma: A Rare Case Report

Ameloblastoma is an odontogenic tumor with diverse clinical behavior and histomorphologic presentations. Basal cell ameloblastoma are extremely rare variants of ameloblastoma. Keratocystic odontogenic tumor (KCOT) is a distinct form of odontogenic cyst that is considered a benign cystic neoplasm and not a cyst. Co-occurrence of these odontogenic tumors has been rarely reported.This paper reports a 34-year old female patient with a unilocular radiolucency around the crown of a partially erupted third molar that was detected accidentally on a routine radiographic examination. She underwent excisional biopsy with a clinical diagnosis of dentigerous cyst. Histopathologic examination revealed a cystic lesion with criteria of OKC and islands and nests reminiscent of basal cell ameloblastoma and acanthomatous ameloblastoma in the stroma. Follow-up showed no recurrence of lesion to date. Due to the rarity of the lesion, the diagnosis was challenging but altogether we made a diagnosis of keratoameloblastoma with basaloid features

Effects of Annealing Temperature on Some Structural and Optical Properties of ZnO Nanoparticles Prepared by a Modified Sol-Gel Combustion Method

Plate-shaped zinc oxide nanoparticles (ZnO-NPs) were successfully synthesized by a modified sol gel combustion method. Zinc acetate, pure water and isopropanol were used as the starting materials. Acetic acid, diethanolamine and nitric acid were used as the polymerization agent, complexing agent and fuel, respectively. The precursors were formed by mixing aqueous solutions of zinc acetate, acetic acid and diethanolamine. Nitric acid was used to dry the produced gel. The resulting xerogel was annealed at 600 degrees C, 650 degrees C and 750 degrees C for 1 h. The synthesized ZnO-NPs were characterized by X-ray diffraction analysis (XRD), thermogravimetric analysis (TGA) and high-magnification transmission electron microscopy (TEM). The XRD results revealed that the samples produced were crystalline with a hexagonal wurtzite phase. The TEM results showed single-crystal ZnO-NPs with nearly hexagonal plate shapes. The optical properties of the ZnO-NPs were studied by UV-visible and Fourier-transform infrared spectroscopy (FTIR). The UV-vis absorption spectra of the ZnO-NPs indicated absorption peaks in the UV region, which were attributed to the band gap of the ZnO-NPs. The results of the FTIR and UV-vis studies showed that the optical properties of the ZnO-NPs depended on the annealing temperature. (C) 2010 Elsevier Ltd and Techna Group S.r.l. All rights reserved

Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series

Abstract Purpose Reporting a special clinical finding after intravitreal bevacizumab monotherapy for retinopathy of prematurity. Methods In a retrospective case series, the clinical courses of five premature infants with similar vitreous changes after a single dose of intravitreal bevacizumab (IVB) injection without additional laser therapy were reported. Results The mean post-conceptional age at IVB injection was 39.8 ± 2.2 (range 37–43) weeks. Localized vitreous syneresis and linear fibrotic vitreous condensation occurred 8.2 ± 2.3 weeks after IVB monotherapy in our patients (15.5% of injections). The mean last post injection visit was 61.6 ± 5.3 weeks (post-conceptional age). Further regression and complete retinal vascularization occurred in all patients. Conclusions Thread-like vitreous condensation with localized vitreous liquefaction may be related to involutional ROP disease itself, combined to anti VEGF therapy and may be a predictor factor for further regression and retinal vascularization. The case series describes a successful response to anti-VEGF monotherapy with no further complications